Lee Jung Sun, Oh Minkyung
Department of Surgery, Haeundae Paik Hospital, College of Medicine, Inje University, Busan, Korea.
Department of Pharmacology, Inje University College of Medicine, Clinical Trial Center, Inje University Busan Paik Hospital, Busan, Korea.
Asian Pac J Cancer Prev. 2020 Apr 1;21(4):1011-1018. doi: 10.31557/APJCP.2020.21.4.1011.
To clarify the limitations of mammography screening for women with dense breasts, we examined breast density and its effects on screening results.
We performed a cross-sectional, observational study on women who underwent mammography. Data from the National Cancer Screening Program(NCSP) from 2009 to 2013 were used. The study population consisted of participants with high breast density. We used a logistic regression analysis to evaluate the relationships between breast density and reproductive factors and screening results according to menopause status.
High breast density was reported for 57.5% of all participants (3,417,319 participants). Screening results indicated breast density of <25%, 25-50%, 51-75%, and ≥76% for 16.4%, 26.3%, 37.8%, and 19.5%, respectively, of participants. According to the screening results, high breast density was correlated with high deferment and recall rates. Reproductive factors, especially parity, breastfeeding, and use of oral contraceptives, had consistent effects on screening results of premenopausal and postmenopausal women. Regardless of menopausal status, age, early onset of menarche (15 years or younger), fewer live births (≤1 birth), and previous benign breast disease were correlated with increased breast density. In postmenopausal women, early-onset menopause and longer-term hormone replacement therapy (≥2 years) also independently increased breast density.
Breast density influenced screening results, which could increase the rate of recall. Breast density was also influenced by reproductive factors, with patterns similar to those of breast cancer risk, regardless of menopausal status. We need to identify high-risk women with high density who would probably benefit from supplemental breast cancer screening.
为阐明乳腺钼靶筛查对乳腺致密型女性的局限性,我们研究了乳腺密度及其对筛查结果的影响。
我们对接受乳腺钼靶检查的女性进行了一项横断面观察性研究。使用了2009年至2013年国家癌症筛查项目(NCSP)的数据。研究人群包括乳腺密度高的参与者。我们采用逻辑回归分析来评估乳腺密度与生殖因素以及根据绝经状态的筛查结果之间的关系。
所有参与者中有57.5%(3417319名参与者)报告乳腺密度高。筛查结果显示,参与者中乳腺密度<25%、25 - 50%、51 - 75%和≥76%的分别占16.4%、26.3%、37.8%和19.5%。根据筛查结果,乳腺密度高与高延期和召回率相关。生殖因素,尤其是产次、母乳喂养和口服避孕药的使用,对绝经前和绝经后女性的筛查结果有一致的影响。无论绝经状态如何,年龄、月经初潮早(15岁或更小)、活产次数少(≤1次分娩)以及既往良性乳腺疾病都与乳腺密度增加相关。在绝经后女性中,早绝经和长期激素替代治疗(≥2年)也独立增加乳腺密度。
乳腺密度影响筛查结果,这可能会提高召回率。乳腺密度也受生殖因素影响,无论绝经状态如何,其模式与乳腺癌风险相似。我们需要识别出可能从补充性乳腺癌筛查中获益的高密度高危女性。